A novel biospecimen

Over more than 20 years of intensive research we have identified rectal mucous as the most effective biological sample for diagnosing GI conditions. It is significantly more precise and effective in testing than stool or blood. Yet this sample type has largely been overlooked in mainstream research.

In response we developed OriCol™, our proprietary, patented, extensively tested medical device. It addresses an urgent need for accurate, affordable in-vitro diagnostics for CRC and advanced adenomas. By enabling reliable, rapid, stress-free sample collection it unlocks the diagnostic potential of the analysis of rectal mucous.

Game-changing diagnostics

Diagnostic tests based on Oricol™-retrieved samples show exceptional accuracy – and the potential to transform and redefine CRC diagnosis.

Our primary focus is on CRC, but we are also actively expanding the potential of OriCol™ into other critical GI-related areas of unmet clinical need, including:

  • Aero-digestive cancers and disease
  • Inflammatory bowel disease (diagnostics and monitoring)

By unlocking the diagnostic potential of rectal mucous, Origin is helping to transform early detection, disease management, and patient outcomes worldwide.

astronomy, moon, nature, night, outdoors, sky

Our mission

We aim to be at the forefront of scientific breakthroughs in the investigation of gastrointestinal diseases, to deliver ground-breaking and innovative products that will benefit patients and healthcare systems globally.